John Rootenberg

John Rootenberg, MD, is an accomplished professional in the digital health and pharmaceutical sectors, currently serving as Principal Director of Digital Safety & Decision Support at Genentech since September 2022. With significant leadership experience, John has held various roles including Board Member at CrowdOptic, Venture Advisor at Meta Health Ventures, and Digital Health Solutions Strategist at Astellas Pharma US. John's expertise encompasses developing product strategies and market research for digital health solutions, managing collaborations in healthcare, and driving engagement strategies to improve patient outcomes. Academic credentials include an MD from Tulane University School of Medicine and a BA in Biochemistry and Molecular Biology from UC San Diego.